BamSEC and AlphaSense Join Forces
Learn More

Inhibikase Therapeutics Inc. – Indentures

NASDAQ: IKT    
Share price (4/9/26): $1.69    
Market cap (4/9/26): $223 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.17
from 10-K 7 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.3
from 8-K 3 pages Inhibikase Therapeutics, Inc. Amendment No. 1 to Series B-1 Warrant to Purchase Common Stock or Pre-Funded Warrants
12/34/56
EX-4.2
from 8-K 3 pages Inhibikase Therapeutics, Inc. Amendment No. 1 to Series A-1 Warrant to Purchase Common Stock or Pre-Funded Warrants
12/34/56
EX-4.1
from 8-K 12 pages The Issuer Has Filed a Registration Statement (Including a Prospectus) With the SEC for the Offering to Which This Communication Relates. Before You Invest, You Should Read the Prospectus in That Registration Statement and Other Documents the Issuer Has Filed With the SEC for More Complete Information About the Issuer and This Offering. You May Get These Documents for Free by Visiting Edgar on the SEC Web Site at WWW.SEC.GOV. Inhibikase Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.5
from S-3 40 pages Inhibikase Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Subordinated Debt Securities
12/34/56
EX-4.4
from S-3 40 pages Inhibikase Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Senior Debt Securities
12/34/56
EX-4.3
from 8-K 22 pages Form of Series B-1 Warrant to Purchase Common Stock or Pre-Funded Warrants
12/34/56
EX-4.2
from 8-K 22 pages Form of Series A-1 Warrant to Purchase Common Stock or Pre-Funded Warrants
12/34/56
EX-4.1
from 8-K 18 pages Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.6
from 8-K 2 pages Amendment to Common Stock Purchase Warrants
12/34/56
EX-4.5
from 8-K 17 pages Series D Common Stock Purchase Warrant Inhibikase Therapeutics, Inc
12/34/56
EX-4.4
from 8-K 17 pages Series C Common Stock Purchase Warrant Inhibikase Therapeutics, Inc
12/34/56
EX-4.3
from 8-K 17 pages Series B Common Stock Purchase Warrant Inhibikase Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 17 pages Series a Common Stock Purchase Warrant Inhibikase Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 12 pages Pre-Funded Common Stock Purchase Warrant Inhibikase Therapeutics, Inc
12/34/56
EX-4.14
from S-1/A 17 pages Inhibikase Therapeutics, Inc. and Equiniti Trust Company, LLC, as Warrant Agent Warrant Agency Agreement Dated as of [ ] __, 2024 Warrant Agency Agreement
12/34/56
EX-4.11
from S-1/A 18 pages Common Stock Purchase Warrant Inhibikase Therapeutics, Inc
12/34/56
EX-4.13
from S-1/A 15 pages Placement Agent Purchase Warrant Inhibikase Therapeutics, Inc
12/34/56
EX-4.12
from S-1/A 12 pages Pre-Funded Common Stock Purchase Warrant Inhibikase Therapeutics, Inc
12/34/56
EX-4.11
from S-1/A 16 pages Common Stock Purchase Warrant Inhibikase Therapeutics, Inc
12/34/56